Related Experiment Video
Updated: Jun 11, 2026
07:30
Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
Sinus laser-assisted closure for pilonidal sinus disease: a prospective single-center study
Francesco Esposito1,2, Dorin Sacrieru1,2, Alexandre Cortes2,3
1Visceral and Digestive Surgery Unit, Grand Hôpital de l'Est Francilien, Meaux, France.
Annals of Coloproctology
|June 10, 2026
Summary
Sinus laser-assisted closure (SiLaC) offers a safe and effective minimally invasive treatment for pilonidal sinus disease (PSD). This method demonstrates rapid recovery, high healing rates, and patient satisfaction, with low recurrence rates.
Area of Science:
- Minimally Invasive Surgery
- Proctology
- Laser Therapy
Background:
- Pilonidal sinus disease (PSD) is a chronic condition impacting young adults.
- Conventional surgical interventions for PSD can involve prolonged recovery and potential recurrence.
- Sinus laser-assisted closure (SiLaC) presents a novel, minimally invasive approach.
Purpose of the Study:
- To evaluate the clinical outcomes of SiLaC for treating PSD.
- To assess the safety and tolerability of the SiLaC procedure.
- To determine patient satisfaction levels following SiLaC treatment.
Main Methods:
- Retrospective analysis of prospectively collected data from 218 patients undergoing SiLaC for PSD.
- Evaluation of demographic data, operative parameters, and postoperative complications.
- Assessment of healing rates, recurrence rates, pain scores, and patient satisfaction via questionnaires.
Main Results:
- The study included 142 male patients (65.1%) with a mean age of 25.3 years.
- Mean operative time was 13.4 minutes; all patients were discharged same-day.
- Overall complication rate was 15.1% (mostly minor abscesses), with a 98.1% healing rate by 45 days and 6.5% recurrence after a second SiLaC procedure. Mean pain score was 2.8, and patient satisfaction was 9.2/10.
Conclusions:
- SiLaC is a safe and effective minimally invasive treatment for PSD.
- The procedure is well-tolerated, offering rapid recovery and favorable short-term outcomes.
- Further research is recommended to optimize SiLaC protocols and evaluate long-term results.
